[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Radchenko et al., 2016 - Google Patents

Separation of 44Ti from proton irradiated scandium by using solid-phase extraction chromatography and design of 44Ti/44Sc generator system

Radchenko et al., 2016

View PDF
Document ID
5990066966944767471
Author
Radchenko V
Meyer C
Engle J
Naranjo C
Unc G
Mastren T
Brugh M
Birnbaum E
John K
Nortier F
Fassbender M
Publication year
Publication venue
Journal of Chromatography A

External Links

Snippet

Abstract Scandium-44 g (half-life 3.97 h [1]) shows promise for positron emission tomography (PET) imaging of longer biological processes than that of the current gold standard, 18 F, due to its favorable decay parameters. One source of 44g Sc is the long-lived …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/38—Flow patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Similar Documents

Publication Publication Date Title
Radchenko et al. Separation of 44Ti from proton irradiated scandium by using solid-phase extraction chromatography and design of 44Ti/44Sc generator system
McNeil et al. Production, purification, and radiolabeling of the 203 Pb/212 Pb theranostic pair
Alliot et al. Cyclotron production of high purity 44m, 44Sc with deuterons from 44CaCO3 targets
Ramogida et al. Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225 Ac
Lin et al. Production of curie quantities of 68Ga with a medical cyclotron via the 68Zn (p, n) 68Ga reaction
Loveless et al. Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47 Sc
Valdovinos et al. Separation of cyclotron-produced 44Sc from a natural calcium target using a dipentyl pentylphosphonate functionalized extraction resin
Radchenko et al. Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development
Nelson et al. Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers
Chakravarty et al. Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications
Chakravarty et al. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix
Hashimoto et al. Production of no-carrier-added 177 Lu via the 176 Yb (n, &;# 947;) 177 Yb &;# 8594; 177 Lu process
Baum et al. Theranostics, Gallium-68, and other radionuclides: a pathway to personalized diagnosis and treatment
Alnahwi et al. Automated radiosynthesis of 68Ga for large-scale routine production using 68Zn pressed target
Tieu et al. Rapid and automated production of [68Ga] gallium chloride and [68Ga] Ga-DOTA-TATE on a medical cyclotron
Chaple et al. Optimized methods for production and purification of Titanium-45
Perron et al. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories
Gumiela Cyclotron production of 99mTc: Comparison of known separation technologies for isolation of 99mTc from molybdenum targets
Wycoff et al. Chromatographic separation of selenium and arsenic: a potential 72Se/72As generator
Mastren et al. Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam
Gott et al. Chromatographic separation of germanium and arsenic for the production of high purity 77As
Mastren et al. A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
Lee et al. Development of a high performance 188W/188Re generator by using a synthetic alumina
Chakravarty et al. Nanocrystalline zirconia: A novel sorbent for the preparation of 188W/188Re generator
Balkin et al. Scale-up of high specific activity 186gRe production using graphite-encased thick 186W targets and demonstration of an efficient target recycling process